Mercado Europeu de Tratamento da Dengue – Tendências da Indústria e Previsão para 2028

Pedido de resumo Pedido de TOC Fale com Analista Fale com o analista  Comprar agora Comprar agora Consulte antes Comprar Consulte antes Relatório de amostra grátis Relatório de amostra grátis

Mercado Europeu de Tratamento da Dengue – Tendências da Indústria e Previsão para 2028

  • Pharmaceutical
  • Publish Reports
  • Feb 2021
  • Europe
  • 350 Páginas
  • Número de tabelas: 220
  • Número de figuras: 60

Europe Dengue Treatment Market

Tamanho do mercado em biliões de dólares

CAGR :  % Diagram

Diagram Período de previsão
2021 –2028
Diagram Tamanho do mercado (ano base )
USD 14.94 Million
Diagram Tamanho do mercado ( Ano de previsão)
USD 73.75 Million
Diagram CAGR
%
Diagram Principais participantes do mercado
  • Manequim1
  • Manequim2
  • Manequim3
  • Manequim4
  • Manequim5

>Mercado europeu de tratamento da dengue, por estirpes (DENV-1, DENV-2, DENV-3, DENV-4 e outras), transmissão (transmissão mosquito-humano, transmissão mãe-filho e outras), tipo (medicamento, Cuidados de suporte, vacinação e outros), gravidade (descomplicada e grave), via de administração (oral e parentérica), modo de compra (prescrição e balcão (OTC)), utilizador final (hospitais, clínicas especializadas, assistência médica domiciliária e outros). ), Canal de Distribuição (Farmácias Hospitalares, Farmácias de Retalho, Farmácias Online e Outras), País (Alemanha, França, Reino Unido, Hungria, Itália, Espanha, Rússia, Polónia, Turquia, Suíça, Países Baixos, Bélgica, Áustria, Noruega, Irlanda, Lituânia e resto da Europa) Tendências e previsões da indústria para 2028

Mercado Europeu de Tratamento da DengueAnálise de Mercado e Insights: Mercado Europeu de Tratamento da Dengue

Espera-se que o mercado de tratamento da dengue ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer com um CAGR de 22,5% no período de previsão de 2021 a 2028 e deverá atingir os 73,75 milhões de dólares. até 2028, face aos 14,94 milhões de dólares em 2020. As iniciativas estratégicas dos participantes do mercado e o advento de programas de vacinação em massa para o tratamento da dengue serão provavelmente os principais impulsionadores que impulsionaram a procura do mercado no período de previsão.

A dengue é uma infeção viral transmitida por mosquitos. Os mosquitos fêmeas transmitem o vírus da dengue principalmente da espécie Aedes aegypti e, em menor grau, do Ae. albopictus. A chikungunya , a febre amarela e o vírus Zika são as doenças causadas por estes mosquitos vetores. A dengue é prevalente nos trópicos, com variabilidade de risco local causada pela precipitação, temperatura, humidade relativa e rápida urbanização não planeada. O diagnóstico da dengue é difícil, uma vez que os seus sinais e sintomas são semelhantes aos da chikungunya, vírus Zika, malária e febre. tifóide. A dengue é uma doença tropical transmitida por mosquitos, causada pelo vírus da dengue (DENV-1, DENV-2, DENV-3, DENV-4). Os sintomas começam geralmente três a catorze dias após a infeção.

O tratamento da dengue é totalmente baseado no tratamento dos sintomas, como no caso da febre alta, o paracetamol é geralmente prescrito para controlar a febre e aliviar as dores. A aspirina e o ibuprofeno devem ser evitados no tratamento da dengue. Em caso de dengue grave, são prestados cuidados de suporte com a monitorização adequada dos sintomas como dor de barriga, hemorragia interna e choque.

O paracetamol, o cloranfenicol, a ciprofloxacina, a ceftriaxona, a ranitidina, o pantoprazol são prescritos na dengue, estando disponíveis no mercado cuidados de suporte e vacinas . A crescente prevalência da dengue, o advento dos programas de vacinação, o crescimento dos seguros médicos nos países emergentes e o aumento do financiamento da I&D deverão impulsionar o crescimento do mercado de tratamento da dengue. Além disso, a iniciativa estratégica do player de mercado e o desenvolvimento tecnológico para detetar a dengue reforçam o crescimento do mercado de tratamento da dengue.

O relatório do mercado de tratamento da dengue fornece detalhes da quota de mercado, novos desenvolvimentos e análise do pipeline de produtos, impacto dos participantes do mercado doméstico e localizado, analisa as oportunidades em termos de bolsas de receitas emergentes, alterações nas regulamentações do mercado, aprovações de produtos, decisões estratégicas, lançamentos de produtos, expansões geográficas e inovações tecnológicas no mercado. Para compreender a análise e o cenário do mercado contacte-nos para um Analyst Brief, a nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir o objetivo desejado.

Mercado Europeu de Tratamento da DengueÂmbito do mercado europeu de tratamento da dengue e dimensão do mercado

O mercado de tratamento da dengue está segmentado com base nas estirpes, transmissão, tipo, gravidade, via de administração, modo de compra, utilizador final e canal de distribuição O crescimento entre segmentos ajuda a analisar os nichos de crescimento e as estratégias para abordar o mercado e determinar as suas principais áreas de aplicação e a diferença nos seus mercados-alvo.

  • Com base na estirpe, o mercado de tratamento da dengue está segmentado em DENV-1, DENV-2, DENV-3, DENV-4, outros. Em 2021, o segmento DENV-2 está a dominar o mercado, uma vez que esta estirpe tem uma elevada prevalência a nível global, o que resulta em maiores casos de infeção por dengue. Embora a dengue também possa ser causada por outras estirpes, a complicação clínica mais dominante é observada no DENV-2.
  • Com base na transmissão, o mercado de tratamento da dengue está segmentado em transmissão mosquito-humano e transmissão mãe-filho. Em 2021, o mosquito para o homem está a dominar o mercado, uma vez que os mosquitos são o principal vetor de transmissão da dengue para as diferentes estirpes do vírus. Quando um mosquito pica uma pessoa infetada, também fica infetado e apanha o vírus no sangue, e quando pica outra pessoa novamente, o vírus é transmitido a essa pessoa. Esta é a razão pela qual a transmissão do mosquito ao homem está a dominar o mercado.
  • Com base no tipo, o mercado de tratamento da dengue está segmentado em medicamentos, cuidados de suporte, vacinação e outros. Em 2021, o segmento dos medicamentos está a dominar o mercado europeu de tratamento da dengue, uma vez que vários medicamentos utilizados no tratamento da dengue estão a ser utilizados para o tratamento da dengue há muito tempo.
  • On the basis of severity, the dengue treatment market is segmented into uncomplicated and severe. In 2021, uncomplicated segment is dominating in the Europe Dengue Treatment Market as the conversion rate of uncomplicated dengue to severe dengue is less than 5% which is the most important reason that the uncomplicated segment is dominating the Europe Dengue Treatment Market.
  • On the basis of route of administration, the dengue treatment market is segmented into oral and parenteral. Oral is sub-segmented into tablets, pills and others. Parenteral is sub-segmented into intravenous, subcutaneous and others. In 2021, oral segment is dominating in the Europe Dengue Treatment Market as most of the drug that are taken to treat the symptoms of dengue are taken oral for pain management and fever management.
  • On the basis of mode of purchase, the dengue treatment market is segmented into prescription and OTC. In 2021, prescription is dominating in the Europe Dengue Treatment Market as the medication and the supportive care is prescribed by the doctor after the confirmation the patient is infected by the dengue virus and the treatment options consist of antibiotics and other medication which are generally not available as prescribed medication only.
  • On the basis of end user, the dengue treatment market is segmented into hospitals, specialty clinics, home healthcare, and others. In 2021, home healthcare is dominating the Europe Dengue Treatment Market as the symptoms of dengue can be managed at home using medications such as pain relief and fever management drugs after the diagnosis.
  • On the basis of distribution channel, the dengue treatment market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others. In 2021, retail pharmacies segment is dominating in the Europe Dengue Treatment Market as after proper diagnosis of dengue most of the prescriptions by patients are filled in retail pharmacies during the total duration of the treatment cycle of the infection.

Dengue Treatment Market Country Level Analysis

The dengue treatment market is analysed and market size information is provided by country, strains, transmission, type, severity, route of administration, mode of purchase, end user and distribution channel.

The countries covered in the dengue treatment market report are Germany, France, U.K., Hungary, Italy, Spain, Russia, Poland, Turkey, Switzerland, Netherlands, Belgium, Austria, Norway, Ireland, Lithuania and Rest of Europe.

Europe is expected to grow with the CAGR in the forecasted period due to growing R&D activities in pharma and biotech sector. Germany is expected to dominate in the Europe market. Germany is one of the leading countries in automation with increasing number of upgradation of the software driven compound management.

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Dados como novas vendas, vendas de reposição, demografia do país, atos regulamentares e tarifas de importação e exportação são alguns dos principais indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, a presença e disponibilidade de marcas globais e os desafios enfrentados devido à concorrência grande ou escassa de marcas locais e nacionais, o impacto dos canais de vendas são considerados, ao mesmo tempo que fornece uma análise de previsão dos dados do país.

A necessidade de tratamento da dengue em áreas urbanas e as iniciativas estratégicas dos players do mercado estão a criar novas oportunidades no mercado de tratamento da dengue

O mercado de tratamento da dengue também fornece análises de mercado detalhadas para o crescimento de cada país, em particular, com vendas de tratamento da dengue, impacto do avanço no tratamento da dengue e mudanças nos cenários regulamentares com o seu apoio ao mercado de tratamento da dengue . Os dados estão disponíveis para o período histórico de 2011 a 2019.

Análise do cenário competitivo e da quota de mercado do tratamento da dengue

O panorama competitivo do mercado de tratamento da dengue fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, localizações e instalações de produção, pontos fortes e fracos da empresa, lançamento de produtos, pipelines de testes de produtos, aprovações de produtos, patentes, largura do produto e respiração, domínio da aplicação, curva da linha de vida da tecnologia. Os dados acima fornecidos estão apenas relacionados com o foco da empresa relacionado com o mercado de tratamento da dengue.

As principais empresas que prestam tratamento para a dengue são a Takeda Pharmaceutical Company Limited, Sanofi, EMERGEX VACCINES, ABIVAX, GlaxoSmithKline plc, Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Hikma Pharmaceuticals PLC, Pfizer Inc., Dr. Baxter, entre outros.

As iniciativas estratégicas dos intervenientes no mercado com investimento de capital para a investigação da dengue estão a colmatar a lacuna entre a dengue e o seu tratamento.

  • Em 2016, a Sun Pharmaceutical Industries Ltd. e o Centro Internacional de Engenharia Genética e Biotecnologia (ICGEB) anunciaram a colaboração para o desenvolvimento de uma nova vacina contra a dengue para a Índia e para o mercado global.

A colaboração, as joint ventures e outras estratégias do player de mercado estão a potenciar o mercado da empresa no mercado de tratamento da dengue, o que também proporciona o benefício para a organização melhorar a sua oferta de produtos de tratamento.


SKU-

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

  • Painel interativo de análise de dados
  • Painel de análise da empresa para oportunidades de elevado potencial de crescimento
  • Acesso de analista de pesquisa para personalização e customização. consultas
  • Análise da concorrência com painel interativo
  • Últimas notícias, atualizações e atualizações Análise de tendências
  • Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Pedido de demonstração

Índice

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE DENGUE TREATMENT MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 STRAINS LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET END USER GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHT

5 PIPELINE ANALYSIS

6 EUROPE DENGUE TREATMENT MARKET: REGULATIONS

6.1 U.S. REGULATORY SCENARIO FOR DENGUE TREATMENT

6.2 EUROPE REGULATORY SCENARIO FOR DENGUE TREATMENT

6.3 DEVELOPING COUNTRIES REGULATORY FRAMEWORK

6.4 LEGISLATION FOR CONTROL OF DENGUE IN SINGAPORE

6.5 DVCRN DEVELOPING VACCINE REGULATORS NETWORK

7 CLINICAL STUDIES FOR DENGUE TREATMENT PRODUCTS.

7.1 SYNTHETIC DRUGS

7.2 BIOMARKER

7.3 DIRECT ACTING ANTIVIRAL DRUGS

8 EPIDEMIOLOGY

9 MARKET OVERVIEW

9.1 DRIVERS

9.1.1 INCREASING INCIDENCE IN DENGUE CASES

9.1.2 ADVENT OF VACCINATION PROGRAMS

9.1.3 INCREASE IN RESEARCH AND DEVELOPMENT FUNDING

9.1.4 ROLE OF IGM AND IGG ANTIBODIES IN DENGUE

9.1.5 GROWTH OF MEDICAL INSURANCE IN EMERGING COUNTRIES

9.2 RESTRAINTS

9.2.1 HIGH COST OF TREATMENT

9.2.2 DEARTH AWARENESS ABOUT THE SYMPTOMS OF DENGUE

9.2.3 LACK OR INSUFFICIENT HEALTHCARE INFRASTRUCTURE

9.3 OPPORTUNITIES

9.3.1 NEED FOR DENGUE TREATMENT IN URBAN AREAS

9.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS

9.3.3 TECHNOLOGICAL ADVANCEMENT IN DENGUE VIRUS DETECTION

9.3.4 INCREASE IN EUROPE TRAVEL AND RELATION WITH DENGUE

9.4 CHALLENGES

9.4.1 PRESENCE OF PREVENTIVE MEASURES FOR DENGUE AND IT’S SPREAD

9.4.2 CHALLENGES IN DETECTION ASSAY FOR DENGUE

9.4.3 ALTERNATIVES FOR DENGUE TREATMENT

10 IMPACT OF COVID-19 ON EUROPE DENGUE TREATMENT MARKET

10.1 IMPACT ON PRICE

10.2 IMPACT ON DEMAND

10.3 IMPACT ON SUPPLY CHAIN

10.4 STRATEGIC DECISION BY MANUFACTURERS

10.5 KEY INITIATIVES BY MARKET PLAYERS DURING COVID-19

10.6 CONCLUSION

11 EUROPE DENGUE TREATMENT MARKET, BY STRAINS

11.1 OVERVIEW

11.2 DENV-3

11.3 DENV-2

11.4 DENV-1

11.5 DENV-4

11.6 OTHERS

12 EUROPE DENGUE TREATMENT MARKET, BY TRANSMISSION

12.1 OVERVIEW

12.2 MOSQUITO-TO-HUMAN TRANSMISSION

12.3 MOTHER-TO-CHILD- TRANSMISSION

12.4 OTHERS

13 EUROPE DENGUE TREATMENT MARKET, BY TYPE

13.1 OVERVIEW

13.2 MEDICATION

13.2.1 ACETAMINOPHEN

13.2.2 ANTIBIOTICS

13.2.2.1 Ciprofloxacin

13.2.2.2 Chloramphenicol

13.2.2.3 Ceftriaxone

13.2.2.4 Ofloxacin

13.2.2.5 Others

13.2.3 IMMUNOGLOBULINS

13.2.4 CORTICOSTEROIDS

13.2.5 ANTI-VIRALS

13.2.6 OTHERS

13.3 SUPPORTIVE CARE

13.4 VACCINATION

13.4.1 DENGVAXIA (CYD-TDV)

13.4.2 DENVAX (TAK-003)

13.4.3 TETRAVAX-DV

13.4.4 TDEN PIV

13.5 OTHERS

14 EUROPE DENGUE TREATMENT MARKET, BY SEVERITY

14.1 OVERVIEW

14.2 UNCOMPLICATED

14.3 SEVERE

15 EUROPE DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION

15.1 OVERVIEW

15.2 ORAL

15.2.1 TABLET

15.2.2 CAPSULES

15.2.3 OTHERS

15.3 PARENTERAL

15.3.1 INTRAVENOUS

15.3.2 SUBCUTANEOUS

15.3.3 OTHERS

16 EUROPE DENGUE TREATMENT MARKET, BY MODE OF PURCHASE

16.1 OVERVIEW

16.2 PRESCRIPTION

16.3 OVER THE COUNTER (OTC)

17 EUROPE DENGUE TREATMENT MARKET, BY END USER

17.1 OVERVIEW

17.2 HOME HEALTHCARE

17.3 HOSPITALS

17.4 SPECIALTY CLINICS

17.5 OTHERS

18 EUROPE DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

18.1 OVERVIEW

18.2 RETAIL PHARMACIES

18.3 HOSPITAL PHARMACY

18.4 ONLINE PHARMACY

18.5 OTHERS

19 EUROPE DENGUE TREATMENT MARKET, BY GEOGRAPHY

19.1 EUROPE

19.1.1 GERMANY

19.1.2 U.K.

19.1.3 FRANCE

19.1.4 ITALY

19.1.5 SPAIN

19.1.6 BELGIUM

19.1.7 AUSTRIA

19.1.8 POLAND

19.1.9 NORWAY

19.1.10 IRELAND

19.1.11 HUNGARY

19.1.12 LITHUANIA

19.1.13 TURKEY

19.1.14 SWITZERLAND

19.1.15 NETHERLANDS

19.1.16 RUSSIA

19.1.17 REST OF EUROPE

20 EUROPE DENGUE TREATMENT MARKET, COMPANY LANDSCAPE

20.1 COMPANY SHARE ANALYSIS: EUROPE

21 SWOT ANALYSIS

22 COMPANY PROFILE

22.1 VIATRIS INC.

22.1.1 COMPANY SNAPSHOT

22.1.2 COMPANY SHARE ANALYSIS

22.1.3 PRODUCT PORTFOLIO

22.1.4 RECENT DEVELOPMENT

22.2 PFIZER INC.

22.2.1 COMPANY SNAPSHOT

22.2.2 REVENUE ANALYSIS

22.2.3 COMPANY SHARE ANALYSIS

22.2.4 PRODUCT PORTFOLIO

22.2.5 RECENT DEVELOPMENTS

22.3 TEVA PHARMACEUTICALS USA, INC. (A SUBSIDIARY OF TEVA PHARMACEUTICAL INDUSTRIES LTD.)

22.3.1 COMPANY SNAPSHOT

22.3.2 REVENUE ANALYSIS

22.3.3 COMPANY SHARE ANALYSIS

22.3.4 PRODUCT PORTFOLIO

22.3.5 RECENT DEVELOPMENT

22.4 PERRIGO COMPANY PLC

22.4.1 COMPANY SNAPSHOT

22.4.2 REVENUE ANALYSIS

22.4.3 COMPANY SHARE ANALYSIS

22.4.4 PRODUCT PORTFOLIO

22.4.5 RECENT DEVELOPMENTS

22.5 GLAXOSMITHKLINE PLC

22.5.1 COMPANY SNAPSHOT

22.5.2 REVENUE ANALYSIS

22.5.3 COMPANY SHARE ANALYSIS

22.5.4 PRODUCT PORTFOLIO

22.5.5 RECENT DEVELOPMENT

22.6 DR. REDDY’S LABORATORIES LTD.

22.6.1 COMPANY SNAPSHOT

22.6.2 REVENUE ANALYSIS

22.6.3 PRODUCT PORTFOLIO

22.6.4 RECENT DEVELOPMENT

22.7 FRESENIUS KABI USA (A SUBSIDIARY OF FRESENIUS SE & CO. KGAA)

22.7.1 COMPANY SNAPSHOT

22.7.2 REVENUE ANALYSIS

22.7.3 PRODUCT PORTFOLIO

22.7.4 RECENT DEVELOPMENTS

22.8 SUN PHARMACEUTICAL INDUSTRIES LTD.

22.8.1 COMPANY SNAPSHOT

22.8.2 REVENUE ANALYSIS

22.8.3 PRODUCT PORTFOLIO

22.8.4 RECENT DEVELOPMENTS

22.9 ABIVAX

22.9.1 COMPANY SNAPSHOT

22.9.2 PRODUCT PORTFOLIO

22.9.3 RECENT DEVELOPMENTS

22.1 AUROBINDO PHARMA

22.10.1 COMPANY SNAPSHOT

22.10.2 REVENUE ANALYSIS

22.10.3 PRODUCT PORTFOLIO

22.10.4 RECENT DEVELOPMENTS

22.11 BAXTER

22.11.1 COMPANY SNAPSHOT

22.11.2 REVENUE ANALYSIS

22.11.3 PRODUCT PORTFOLIO

22.11.4 RECENT DEVELOPMENT

22.12 EMERGEX VACCINES

22.12.1 COMPANY SNAPSHOT

22.12.2 PRODUCT PORTFOLIO

22.12.3 RECENT DEVELOPMENTS

22.13 HIKMA PHARMACEUTICALS PLC

22.13.1 COMPANY SNAPSHOT

22.13.2 REVENUE ANALYSIS

22.13.3 PRODUCT PORTFOLIO

22.13.4 RECENT DEVELOPMENT

22.14 SANOFI

22.14.1 COMPANY SNAPSHOT

22.14.2 REVENUE ANALYSIS

22.14.3 PRODUCT PORTFOLIO

22.14.4 RECENT DEVELOPMENTS

22.15 TAKEDA PHARMACEUTICAL COMPANY LIMITED

22.15.1 COMPANY SNAPSHOT

22.15.2 REVENUE ANALYSIS

22.15.3 PRODUCT PORTFOLIO

22.15.4 RECENT DEVELOPMENTS

23 QUESTIONNAIRE

24 RELATED REPORTS

Lista de Tabela

LIST OF TABLES

TABLE 1 EUROPE DENGUE TREATMENT MARKET, PIPELINE ANALYSIS

TABLE 2 THREE PHASES FOR HEALTH PROTECTION OUTLINED BY THE EUROPEAN WORLD HEALTH ORGANIZATION

TABLE 3 EUROPE DENGUE TREATMENT MARKET, BY STRAINS 2019-2028 (USD MILLION)

TABLE 4 EUROPE DENV-3 IN DENGUE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 EUROPE DENV-2 IN DENGUE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 EUROPE DENV-1 IN DENGUE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 EUROPE DENV-4 IN DENGUE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 EUROPE OTHERS IN DENGUE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 EUROPE DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 10 EUROPE MOSQUITO-TO-HUMAN TRANSMISSION IN DENGUE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 EUROPE MOTHER-TO-CHILD TRANSMISSION IN DENGUE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 EUROPE OTHERS IN DENGUE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 EUROPE DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 14 EUROPE MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 15 EUROPE MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION), BY REGION

TABLE 16 EUROPE ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 17 EUROPE OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 18 EUROPE SUPPORTIVE CARE IN DENGUE TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 19 EUROPE VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 20 EUROPE VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION), BY REGION

TABLE 21 EUROPE OTHERS IN DENGUE TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION), BY REGION

TABLE 22 EUROPE DENGUE TREATMENT MARKET, BY SEVERITY 2019-2028 (USD MILLION)

TABLE 23 EUROPE UNCOMPLICATED IN DENGUE TREATMENT MARKET, BY REGION 2019-2028 (USD MILLION)

TABLE 24 EUROPE SEVERE IN DENGUE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 EUROPE DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 26 EUROPE ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION), BY REGION

TABLE 27 EUROPE ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 28 EUROPE PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION), BY REGION

TABLE 29 EUROPE PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 30 EUROPE DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 31 EUROPE PRESCRIPTION IN DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION), BY REGION

TABLE 32 EUROPE OVER THE COUNTER (OTC) IN DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION), BY REGION

TABLE 33 EUROPE DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 34 EUROPE HOME HEALTHCARE IN DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION), BY REGION

TABLE 35 EUROPE HOSPITALS IN DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION), BY REGION

TABLE 36 EUROPE SPECIALTY CLINICS IN DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION), BY REGION

TABLE 37 EUROPE OTHERS IN DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION), BY REGION

TABLE 38 EUROPE DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 39 EUROPE DIRECT TENDER IN DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION), BY REGION

TABLE 40 EUROPE HOSPITAL PHARMACY IN DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION), BY REGION

TABLE 41 EUROPE ONLINE PHARMACY IN DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION), BY REGION

TABLE 42 EUROPE HOSPITALS IN DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION), BY REGION

TABLE 43 EUROPE DENGUE TREATMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 44 EUROPE DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 45 EUROPE DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 46 EUROPE DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 47 EUROPE MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 48 EUROPE ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 49 EUROPE OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 50 EUROPE VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 51 EUROPE DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 52 EUROPE DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 53 EUROPE ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 54 EUROPE PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 55 EUROPE DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 56 EUROPE DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 57 EUROPE DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 58 GERMANY DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 59 GERMANY DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 60 GERMANY DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 61 GERMANY MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 62 GERMANY ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 63 GERMANY OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 64 GERMANY VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 65 GERMANY DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 66 GERMANY DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 67 GERMANY ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 68 GERMANY PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 69 GERMANY DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 70 GERMANY DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 71 GERMANY DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 72 U.K. DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 73 U.K. DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 74 U.K. DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 75 U.K. MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 76 U.K. ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 77 U.K. OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 78 U.K. VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 79 U.K. DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 80 U.K. DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 81 U.K. ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 82 U.K. PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 83 U.K. DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 84 U.K. DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 85 U.K. DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 86 FRANCE DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 87 FRANCE DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 88 FRANCE DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 89 FRANCE MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 90 FRANCE ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 91 FRANCE OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 92 FRANCE VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 93 FRANCE DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 94 FRANCE DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 95 FRANCE ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 96 FRANCE PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 97 FRANCE DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 98 FRANCE DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 99 FRANCE DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 100 ITALY DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 101 ITALY DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 102 ITALY DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 103 ITALY MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 104 ITALY ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 105 ITALY OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 106 ITALY VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 107 ITALY DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 108 ITALY DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 109 ITALY ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 110 ITALY PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 111 ITALY DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 112 ITALY DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 113 ITALY DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 114 SPAIN DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 115 SPAIN DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 116 SPAIN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 117 SPAIN MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 118 SPAIN ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 119 SPAIN OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 120 SPAIN VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 121 SPAIN DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 122 SPAIN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 123 SPAIN ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 124 SPAIN PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 125 SPAIN DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 126 SPAIN DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 127 SPAIN DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 128 BELGIUM DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 129 BELGIUM DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 130 BELGIUM DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 131 BELGIUM MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 132 BELGIUM ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 133 BELGIUM OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 134 BELGIUM VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 135 BELGIUM DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 136 BELGIUM DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 137 BELGIUM ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 138 BELGIUM PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 139 BELGIUM DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 140 BELGIUM DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 141 BELGIUM DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 142 AUSTRIA DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 143 AUSTRIA DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 144 AUSTRIA DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 145 AUSTRIA MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 146 AUSTRIA ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 147 AUSTRIA OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 148 AUSTRIA VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 149 AUSTRIA DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 150 AUSTRIA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 151 AUSTRIA ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 152 AUSTRIA PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 153 AUSTRIA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 154 AUSTRIA DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 155 AUSTRIA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 156 POLAND DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 157 POLAND DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 158 POLAND DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 159 POLAND MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 160 POLAND ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 161 POLAND OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 162 POLAND VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 163 POLAND DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 164 POLAND DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 165 POLAND ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 166 POLAND PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 167 POLAND DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 168 POLAND DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 169 POLAND DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 170 NORWAY DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 171 NORWAY DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 172 NORWAY DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 173 NORWAY MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 174 NORWAY ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 175 NORWAY OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 176 NORWAY VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 177 NORWAY DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 178 NORWAY DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 179 NORWAY ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 180 NORWAY PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 181 NORWAY DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 182 NORWAY DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 183 NORWAY DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 184 IRELAND DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 185 IRELAND DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 186 IRELAND DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 187 IRELAND MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 188 IRELAND ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 189 IRELAND OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 190 IRELAND VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 191 IRELAND DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 192 IRELAND DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 193 IRELAND ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 194 IRELAND PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 195 IRELAND DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 196 IRELAND DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 197 IRELAND DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 198 HUNGARY DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 199 HUNGARY DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 200 HUNGARY DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 201 HUNGARY MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 202 HUNGARY ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 203 HUNGARY OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 204 HUNGARY VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 205 HUNGARY DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 206 HUNGARY DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 207 HUNGARY ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 208 HUNGARY PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 209 HUNGARY DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 210 HUNGARY DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 211 HUNGARY DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 212 LITHUANIA DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 213 LITHUANIA DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 214 LITHUANIA DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 215 LITHUANIA MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 216 LITHUANIA ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 217 LITHUANIA OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 218 LITHUANIA VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 219 LITHUANIA DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 220 LITHUANIA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 221 LITHUANIA ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 222 LITHUANIA PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 223 LITHUANIA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 224 LITHUANIA DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 225 LITHUANIA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 226 TURKEY DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 227 TURKEY DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 228 TURKEY DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 229 TURKEY MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 230 TURKEY ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 231 TURKEY OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 232 TURKEY VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 233 TURKEY DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 234 TURKEY DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 235 TURKEY ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 236 TURKEY PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 237 TURKEY DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 238 TURKEY DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 239 TURKEY DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 240 SWITZERLAND DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 241 SWITZERLAND DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 242 SWITZERLAND DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 243 SWITZERLAND MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 244 SWITZERLAND ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 245 SWITZERLAND OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 246 SWITZERLAND VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 247 SWITZERLAND DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 248 SWITZERLAND DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 249 SWITZERLAND ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 250 SWITZERLAND PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 251 SWITZERLAND DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 252 SWITZERLAND DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 253 SWITZERLAND DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 254 NETHERLANDS DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 255 NETHERLANDS DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 256 NETHERLANDS DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 257 NETHERLANDS MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 258 NETHERLANDS ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 259 NETHERLANDS OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 260 NETHERLANDS VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 261 NETHERLANDS DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 262 NETHERLANDS DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 263 NETHERLANDS ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 264 NETHERLANDS PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 265 NETHERLANDS DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 266 NETHERLANDS DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 267 NETHERLANDS DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 268 RUSSIA DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 269 RUSSIA DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 270 RUSSIA DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 271 RUSSIA MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 272 RUSSIA ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 273 RUSSIA OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 274 RUSSIA VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 275 RUSSIA DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 276 RUSSIA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 277 RUSSIA ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 278 RUSSIA PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 279 RUSSIA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 280 RUSSIA DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 281 RUSSIA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 282 REST OF EUROPE DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

 

Lista de Figura

LIST OF FIGURES

FIGURE 1 EUROPE DENGUE TREATMENT MARKET: SEGMENTATION

FIGURE 2 EUROPE DENGUE TREATMENT MARKET : DATA TRIANGULATION

FIGURE 3 EUROPE DENGUE TREATMENT MARKET: DROC ANALYSIS

FIGURE 4 EUROPE DENGUE TREATMENT MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE DENGUE TREATMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE DENGUE TREATMENT MARKET: MULTIVARIATE MODELLING

FIGURE 7 EUROPE DENGUE TREATMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE DENGUE TREATMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE DENGUE TREATMENT MARKET: MARKET END USER GRID

FIGURE 10 EUROPE DENGUE TREATMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 EUROPE DENGUE TREATMENT MARKET: SEGMENTATION

FIGURE 12 INCREASING INCIDENCE OF DENGUE CASES AND ADVENT OF VACCINATION PROGRAMS ARE DRIVING THE EUROPE DENGUE TREATMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 FUNGAL DENGUE TREATMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE DENGUE TREATMENT MARKET IN 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF EUROPE DENGUE TREATMENT MARKET

FIGURE 15 EUROPE DENGUE TREATMENT MARKET: BY STRAINS, 2020

FIGURE 16 EUROPE DENGUE TREATMENT MARKET: BY STRAINS, 2020-2028 (USD MILLION)

FIGURE 17 EUROPE DENGUE TREATMENT MARKET: BY STRAINS, CAGR (2021-2028)

FIGURE 18 EUROPE DENGUE TREATMENT MARKET: BY STRAINS, LIFELINE CURVE

FIGURE 19 EUROPE DENGUE TREATMENT MARKET: BY TRANSMISSION, 2020

FIGURE 20 EUROPE DENGUE TREATMENT MARKET: BY TRANSMISSION 2020-2028 (USD MILLION)

FIGURE 21 EUROPE DENGUE TREATMENT MARKET: BY TRANSMISSION, CAGR (2021-2028)

FIGURE 22 EUROPE DENGUE TREATMENT MARKET: BY TRANSMISSION, LIFELINE CURVE

FIGURE 23 EUROPE DENGUE TREATMENT MARKET: BY TYPE, 2020

FIGURE 24 EUROPE DENGUE TREATMENT MARKET: BY TYPE, 2020-2028 (USD MILLION)

FIGURE 25 EUROPE DENGUE TREATMENT MARKET: BY TYPE, CAGR (2020-2028)

FIGURE 26 EUROPE DENGUE TREATMENT MARKET: BY TYPE, LIFELINE CURVE

FIGURE 27 EUROPE DENGUE TREATMENT MARKET: BY SEVERITY, 2020

FIGURE 28 EUROPE DENGUE TREATMENT MARKET: BY SEVERITY , 2020-2028 (USD MILLION)

FIGURE 29 EUROPE DENGUE TREATMENT MARKET: BY SEVERITY, CAGR (2021-2028).

FIGURE 30 EUROPE DENGUE TREATMENT MARKET: BY SEVERITY, LIFELINE CURVE

FIGURE 31 EUROPE DENGUE TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2020

FIGURE 32 EUROPE DENGUE TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2020-2028 (USD MILLION)

FIGURE 33 EUROPE DENGUE TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2020-2028)

FIGURE 34 EUROPE DENGUE TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 35 EUROPE DENGUE TREATMENT MARKET: BY MODE OF PURCHASE, 2020

FIGURE 36 EUROPE DENGUE TREATMENT MARKET: BY MODE OF PURCHASE, 2020-2028 (USD MILLION)

FIGURE 37 EUROPE DENGUE TREATMENT MARKET: BY MODE OF PURCHASE, CAGR (2020-2028)

FIGURE 38 EUROPE DENGUE TREATMENT MARKET: BY MODE OF PURCHASE, LIFELINE CURVE

FIGURE 39 EUROPE DENGUE TREATMENT MARKET: BY END USER, 2020

FIGURE 40 EUROPE DENGUE TREATMENT MARKET: BY END USER, 2020-2028 (USD MILLION)

FIGURE 41 EUROPE DENGUE TREATMENT MARKET: BY END USER, CAGR (2020-2028)

FIGURE 42 EUROPE DENGUE TREATMENT MARKET: BY END USER, LIFELINE CURVE

FIGURE 43 EUROPE DENGUE TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 44 EUROPE DENGUE TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)

FIGURE 45 EUROPE DENGUE TREATMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2028)

FIGURE 46 EUROPE DENGUE TREATMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 47 EUROPE DENGUE TREATMENT MARKET: SNAPSHOT (2020)

FIGURE 48 EUROPE DENGUE TREATMENT MARKET: BY COUNTRY (2020)

FIGURE 49 EUROPE DENGUE TREATMENT MARKET: BY COUNTRY (2021 & 2028)

FIGURE 50 EUROPE DENGUE TREATMENT MARKET: BY COUNTRY (2021 & 2028)

FIGURE 51 EUROPE DENGUE TREATMENT MARKET: BY STRAINS (2021-2028)

FIGURE 52 EUROPE DENGUE TREATMENT MARKET: COMPANY SHARE 2020 (%)

 

View Detailed Information Right Arrow

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Perguntas frequentes

The market is segmented based on , By Strains (DENV-1, DENV-2, DENV-3, DENV-4 and Others), Transmission (Mosquito-To-Human Transmission, Mother-To-Child Transmission and Others), Type (Medication, Supportive Care, Vaccination and Others), Severity (Uncomplicated and Severe), Route of Administration (Oral and Parenteral), Mode of Purchase (Prescription and Over the Counter (OTC)), End User (Hospitals, Specialty Clinics, Home Healthcare and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others), Country (Germany, France, U.K., Hungary, Italy, Spain, Russia, Poland, Turkey, Switzerland, Netherlands, Belgium, Austria, Norway, Ireland, Lithuania and Rest of Europe) Industry Trends and Forecast to 2028 .
The Europe Dengue Treatment Market size was valued at USD 14.94 USD Million in 2020.
The Europe Dengue Treatment Market is projected to grow at a CAGR of 22.5% during the forecast period of 2021 to 2028.